BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025

  April 29, 2025

   · 

  3 min read
• Press Releases

  Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma

  April 29, 2025

   · 

  6 min read
• Press Releases

  Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

  April 29, 2025

   · 

  3 min read
• Press Releases

  U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

  April 29, 2025

   · 

  15 min read
• Press Releases

  Calluna Announces Three Poster Presentations at the 2025 American Thoracic Society International Conference

  April 29, 2025

   · 

  2 min read
• Press Releases

  ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

  April 29, 2025

   · 

  1 min read
• Press Releases

  Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

  April 29, 2025

   · 

  23 min read
• Press Releases

  Dianthus Therapeutics to Participate in Two Upcoming Investor Events

  April 29, 2025

   · 

  1 min read
• Press Releases

  Corning Announces Strong First-Quarter 2025 Financial Results(1) and Reiterates Confidence in Springboard Plan

  April 29, 2025

   · 

  14 min read
• Press Releases

  Henry Meds Brings Hormone Replacement Therapies and Personalized Care to Patients Suffering with Menopause and Perimenopause Symptoms

  April 29, 2025

   · 

  2 min read